--- title: Buy Daklinza (Daclatasvir) 60mg Pills Online description: Daklinza (Daclatasvir) 60mg Pills are used in combination therapy for hepatitis C treatment. Order from our secure pharmacy for trusted medication and reliable delivery service. type: product language: en url: https://liabilis.com/order-daklinza-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 540.99 price_max: 912.99 currency: USD offers: - name: 60mg x 28 pills price: 540.99 - name: 60mg x 56 pills price: 912.99 --- # Buy Daklinza (Daclatasvir) 60mg Pills Online Daklinza, containing the active ingredient Daclatasvir, is a branded antiviral medication developed by Bristol Myers Squibb. It is used in combination with other antivirals to treat chronic hepatitis C infection in adults, specifically targeting certain genotypes of the virus. This medication helps achieve viral clearance and prevent liver damage progression. Our online pharmacy offers Daklinza in 60mg pills for convenient access to this effective treatment. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **60mg** | 28 pills | **$540.99** | $19.32 | In Stock | | **60mg** | 56 pills | **$912.99** | $16.30 | In Stock | [Buy Now](https://liabilis.com/order-daklinza-online-en.html) ## Introduction Daklinza is an oral antiviral medication indicated for the treatment of chronic hepatitis C virus (HCV) infection. Its active ingredient is daclatasvir, a direct-acting antiviral (DAA) that targets the NS5A protein of HCV. The product is supplied as a 60 mg tablet. Daklinza belongs to the class of NS5A inhibitors and is used in combination regimens to achieve sustained virologic response in adults with specific HCV genotypes. ## Quick Reference Facts **Active Ingredient** : daclatasvir **Form** : pill 60 mg **Primary Uses** : treatment of chronic hepatitis C infection (genotype-dependent regimens) ## What is Daklinza? Daklinza is a tablet formulation that contains the antiviral agent daclatasvir. It is classified as an NS5A inhibitor, a key component of modern hepatitis C therapy. The drug was developed by Bristol-Myers Squibb and received regulatory approval in several jurisdictions for use in combination with other DAAs. Although Daklinza is marketed under a brand name, generic versions containing the same active molecule are available worldwide, offering cost-effective alternatives to the branded product. ## How Daklinza Works Daclatasvir binds to the non-structural protein 5A (NS5A) of hepatitis C virus. NS5A is essential for viral RNA replication and assembly of infectious particles. By inhibiting NS5A, daclatasvir disrupts the formation of the replication complex, leading to a rapid decline in viral load. The drug exhibits high potency across multiple HCV genotypes, but its effectiveness is maximized when combined with a polymerase inhibitor (e.g., sofosbuvir) or a protease inhibitor. After oral administration, daclatasvir is absorbed quickly, reaching peak plasma concentrations within 4-6 hours. It is metabolized primarily by CYP3A4 and excreted in feces, with a terminal half-life of approximately 12-15 hours, supporting once-daily dosing. ## Conditions Treated with Daklinza - **Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) in combination therapy** Daklinza enhances viral clearance when paired with complementary DAAs, helping patients achieve a sustained virologic response (SVR) and reducing the risk of liver cirrhosis. - **Compensated Liver Disease due to HCV** By eliminating the virus, Daklinza can halt disease progression in patients with preserved liver function, decreasing the need for liver transplantation. - **HCV infection in patients with HIV co-infection (when appropriate)** Clinical studies demonstrate comparable antiviral efficacy in co-infected individuals, provided drug-drug interactions are managed. ## Is Daklinza the Right Medication for You? Daklinza is appropriate for adult patients with chronic hepatitis C who have been evaluated for genotype, liver disease stage, and prior treatment history. It is especially beneficial when an NS5A-based regimen is recommended by clinical guidelines. Patients with severe renal impairment (eGFR < 30 mL/min) should be assessed carefully, as limited data exist. Contraindications include known hypersensitivity to daclatasvir or any excipients, and concurrent use of strong CYP3A inducers (e.g., rifampin) which markedly reduce drug exposure. Women who are pregnant or breastfeeding must avoid Daklinza because safety data are insufficient. Clinicians typically reserve this therapy for individuals who can adhere to daily dosing and who have no uncontrolled comorbidities that could interfere with antiviral effectiveness. ## Buying Daklinza from [our online pharmacy](https://liabilis.com/order-daklinza-online-en.html) ### Why Choose Our Service? Access to high-quality antiviral therapy can be challenging due to cost and geographic restrictions. Our platform connects patients with verified sources, helping to bridge gaps in availability while keeping expenses manageable. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every shipment undergoes strict verification against manufacturer specifications and regulatory standards. ### Pricing & Access Because we source generic equivalents of daclatasvir, patients often save a substantial percentage compared with brand-name pricing. Our pricing structure is transparent, with no hidden fees, allowing you to plan treatment costs confidently. ### Discreet Delivery All orders are packaged in unmarked, tamper-evident containers. Standard shipping arrives within 7 days for express service, while economy airmail typically reaches you in about three weeks, maintaining privacy throughout the process. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing**: One 60 mg tablet taken orally once daily, in combination with the prescribed partner antiviral(s). - **Missed dose**: If a dose is forgotten, take it as soon as remembered unless it is less than 12 hours until the next scheduled dose; in that case, skip the missed tablet and resume the regular schedule. Do not double-dose. - **Overdose**: While a specific overdose threshold has not been established, ingesting more than the prescribed amount may increase the risk of hepatic enzyme elevation and should prompt immediate medical evaluation. Contact emergency services or a poison control center. - **Administration tips**: The tablet can be taken with or without food. Alcohol consumption should be limited, as heavy drinking can exacerbate liver injury. Patients should avoid operating heavy machinery until they know how the medication affects them, although most experience no impairment. ## Safety Information ### ⚠️ Who Should Not Take Daklinza - Individuals with a documented hypersensitivity to daclatasvir or any tablet excipient. - Patients receiving strong CYP3A inducers (e.g., rifampin, carbamazepine, St. John’s wort) because therapeutic levels are reduced. - Women who are pregnant, planning to become pregnant, or breastfeeding; insufficient safety data exist. ### Common Side Effects - **Fatigue** (occurs in up to 20 % of users) - generally mild and self-limiting. - **Headache** (≈15 %) - may respond to over-the-counter analgesics. - **Nausea** (≈10 %) - taking the tablet with food can alleviate discomfort. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe hepatic injury** - marked elevation of ALT/AST or jaundice. - **Allergic reactions** - rash, pruritus, facial swelling, or difficulty breathing. - **Cardiac arrhythmias** - rare but reported in patients with pre-existing conduction disorders. If any of these occur, discontinue the medication and obtain urgent medical attention. ### Drug & Food Interactions - **Strong CYP3A inducers** (rifampin, carbamazepine, phenytoin, St. John’s wort) → ↓ daclatasvir exposure; avoid co-administration. - **Strong CYP3A inhibitors** (ketoconazole, clarithromycin, protease inhibitors boosted with ritonavir) → ↑ daclatasvir exposure; dose adjustment may be required. - **Antacids** - no clinically significant interaction has been reported, but routine spacing of 2 hours is reasonable. - **Alcohol** - excessive intake can worsen liver disease; moderation is advised. ## Off-Label and Investigational Uses of Daklinza - **Post-transplant hepatitis C prophylaxis** - early-phase studies suggest that NS5A inhibitors may reduce reinfection risk after liver transplantation, but formal approval is pending. - **HCV-related mixed cryoglobulinemia** - case series indicate viral clearance can improve cryoglobulin-mediated vasculitis, though evidence remains limited. - **Combination with novel polymerase inhibitors** - ongoing trials explore shorter treatment durations (e.g., 8-week regimens) in select genotype-3 patients. Off-label use should only be considered under the direct supervision of a qualified healthcare provider, as efficacy and safety have not been formally established by regulatory agencies. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place, protected from moisture and light. - Keep the container tightly closed and out of reach of children. - Do not use the medication beyond the printed expiration date; discard expired tablets according to local pharmacy waste guidelines. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Daklinza tablets?** Yes. Keep the medication in its original labeled container, carry a copy of the prescription or dispensing record, and be aware of the destination country’s import regulations for prescription medicines. - **Will taking Daklinza affect my ability to drive or operate machinery?** Most patients do not experience impairment. However, if you notice dizziness, fatigue, or visual changes, refrain from operating vehicles until symptoms resolve. **Product Information** - **What does a Daklinza tablet look like?** The tablet is a round, white pill marked with “60 mg” on one side. In some regions, generic equivalents may have different imprint codes but contain the same active ingredient. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, magnesium stearate, and microcrystalline cellulose. Patients with severe lactose intolerance should discuss alternatives with their provider. **Regulatory & Safety Nuances** - **Will Daklinza show up on a standard drug test?** Daclatasvir is not typically screened for in occupational or athletic drug-testing panels, as it is not classified as a performance-enhancing or controlled substance. - **Is Daklinza safe for elderly patients?** Age alone is not a contraindication, but older adults often have comorbidities and polypharmacy that increase the risk of drug-drug interactions. A thorough medication review is recommended. **Scientific & Clinical Curiosity** - **What key trials led to Daklinza’s approval?** Phase III studies such as the ALLY-3 and HCV-DYNAMIC trials demonstrated high SVR rates when daclatasvir was combined with sofosbuvir or other DAAs across multiple genotypes. - **How does Daklinza compare to earlier NS5A inhibitors?** Daclatasvir exhibits a longer half-life and higher barrier to resistance than first-generation NS5A agents, allowing once-daily dosing and broader genotype coverage. ## Glossary **NS5A Inhibitor** : A class of antiviral agents that block the hepatitis C virus NS5A protein, essential for viral replication and assembly. **Sustained Virologic Response (SVR)** : The absence of detectable HCV RNA in blood 12 weeks after completing therapy, considered a cure. **CYP3A4** : A liver enzyme that metabolizes many drugs; inducers increase its activity, while inhibitors decrease it, affecting drug concentrations. ## Disclaimer The information presented about Daklinza is intended for general educational purposes and does not substitute professional medical consultation. All therapeutic choices, including those involving off-label applications, should be made under the guidance of a qualified healthcare professional. Readers are presumed to be responsible adults capable of informed health decisions. [our online pharmacy](https://liabilis.com/order-daklinza-online-en.html) provides access to Daklinza for individuals who may encounter limited availability through conventional channels or who seek cost-effective alternatives. Prior to initiating, altering, or stopping any medication, please discuss your specific situation with a qualified practitioner.